KN046 in Subjects With Advanced Solid Tumors and Lymphoma

NCT03733951 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

139

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Lymphoma

Interventions

DRUG: KN046

Sponsor

Jiangsu Alphamab Biopharmaceuticals Co., Ltd